Agoracom Blog

Novamind $NM.ca Announces Strategic Investment in #Bionomics $BNOEF to Support #PTSD Clinical Trial $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 8:20 AM on Thursday, February 11th, 2021

Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment

  • Announced that it has made a strategic investment of AU$827,486 (approximately CAN$810,000, the “Strategic Investment”), in Bionomics Limited (“Bionomics”) (ASX:BNO)(OTCQB:BNOEF) (Germany:AU000000BNO5), a biopharmaceutical company dedicated to developing better treatments for central nervous system disorders.
  • In addition, Cedar Clinical Research (“CCR”), a wholly owned subsidiary of Novamind based in Springville, Utah, will be evaluated by Bionomics as a clinical research site to conduct Bionomics’ Phase IIb trial examining BNC210.
  • BNC210 has received Fast Track Designation from the U.S. Food and Drug Administration for the treatment of post-traumatic stress disorder (PTSD).

TORONTO, ON / February 11, 2021 / Novamind Inc. (CSE:NM) (“Novamind”), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has made a strategic investment of AU$827,486 (approximately CAN$810,000, the “Strategic Investment”), in Bionomics Limited (“Bionomics”) (ASX:BNO)(OTCQB:BNOEF) (Germany:AU000000BNO5), a biopharmaceutical company dedicated to developing better treatments for central nervous system disorders.

In addition, Cedar Clinical Research (“CCR”), a wholly owned subsidiary of Novamind based in Springville, Utah, will be evaluated by Bionomics as a clinical research site to conduct Bionomics’ Phase IIb trial examining BNC210. BNC210 has received Fast Track Designation from the U.S. Food and Drug Administration for the treatment of post-traumatic stress disorder (PTSD).

With its investment in Bionomics, Novamind joins a group of well-known investors that specialize in psychedelics and biotech: Apeiron Investments, Biotech Value Fund, Merck & Co., Mike Novogratz, and Peter Thiel, an early investor in ATAI Life Sciences.

Novamind’s Strategic Investment is included in Bionomics’ latest round of financing, which was underwritten by Apeiron Investments and received commitments for AU$16,000,000 (approximately CAN$15,680,000, the “Bionomics Financing”). Novamind will purchase a total of 5,706,800 common shares in the Bionomics Financing, at AU$0.145 per share, a 20% discount to the 30-day volume weighted average price as of February 5th, 2021. Proceeds from the Bionomics Financing will support the initiation of a Phase IIb trial for BNC210, planned for mid-2021.

Bionomics intends to evaluate Cedar Clinical Research’s deep expertise in facilitating Phase I to Phase IV clinical trials for leading pharmaceutical companies, and how it may potentially serve as a research site for Bionomics’ Phase IIb clinical trial examining BNC210 in PTSD patients.

Cedar Clinical Research, led by Novamind’s Chief Medical Officer, Dr. Reid Robison, is currently contracted for seven clinical trials with various sponsors, including leading pharmaceutical companies. Dr. Robison has led over 100 clinical trials in neuropsychiatry, researching a spectrum of psychiatric conditions, including PTSD.

“I’m happy to welcome Novamind as a strategic investor in Bionomics,” said Dr. Errol De Souza, Executive Chairman of Bionomics. “Dr. Robison and the team at Cedar Clinical Research have unique experience related to clinical trials for mental health therapeutics.”

Yaron Conforti, CEO and Director of Novamind, added, “We are pleased to participate in Bionomics’ financing to support the development of its novel drug candidate for the treatment of PTSD. Cedar Clinical Research has unique expertise in PTSD research, and we look forward to the opportunity to contribute to the development of BNC210.”

To learn more about Cedar Clinical Research, please visit cedarclinicalresearch.com.

About Bionomics

Bionomics is a global, clinical stage biopharmaceutical company leveraging its proprietary platform technologies to discover and develop a deep pipeline of best in class, novel drug candidates. Bionomics’ lead drug candidate BNC210, currently in development for initiation of a second Phase II trial for the treatment of PTSD, is a novel, proprietary negative allosteric modulator of the alpha-7 (α7) nicotinic acetylcholine receptor. Beyond BNC210, Bionomics has a strategic partnership with Merck & Co., Inc (known as MSD outside the United States and Canada). To learn more, please visit bionomics.com.au.

About Novamind

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca.

Contact Information

Novamind
Yaron Conforti, CEO and Director
Telephone: +1 (647) 953 9512
Bill Mitoulas, Investor Relations
Email: [email protected]

Forward-Looking Statements

This news release contains forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations including the risks detailed from time to time in the Company’s public disclosure. The reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.

SOURCE: Novamind Inc.

Read More: https://agoracom.com/ir/Novamind/forums/discussion/topics/755165-novamind-announces-strategic-investment-in-bionomics-to-support-ptsd-clinical-trial/messages/2303206#message

VIDEO – @goplantx $VEGA $PLTXF Reports Record Revenue of Over $1M For Month of January $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 6:33 PM on Wednesday, February 10th, 2021

The paradigm shifting, parabolic growth of plant based foods and a plant based life is unstoppable, with the plant-based food market alone expected to reach $74.2 billion by 2027.

PlantX Life (VEGA:CSE) (PLTXF:OTCQB) Is The One Stop Shop For Everything Plant Based + The  Digital Face of The Plant -Based Community   More than just lip service, $VEGA reported revenue of $1,089,502 for the month of January 2021.

$VEGA is just getting started, with a line up of plant based products and services that includes:

  • Plant Based Meal Delivery (20 meals)
  • Plant Based Snack Products
  • Plant Based Pet foods
  • Plant Based Restaurant Locator
  • Plant Based Recipes
  • Plant Based Essentials …. Like Chocolate (Essential?  You Bet)
  • And …… Plant Based …. PLANTS (It’s A BIG Business!)

From an operations point of view, VEGA is already in full swing and growing FAST

  • Already Operating In Canada
  • US Online Operations Kick Off With $USD 25M MIN of PlantX products YEAR 1
    • 6% Royalty Fee to PlantX on gross USA revenues
  • US Bricks & Mortar with San Diego flagship store opening soon.
  • £8 million Acquisition of Bloombox In The UK, generating millions in revenue
  • Closed $11.5M Non-Brokered Private Placement
  • ….. and  Application To List On NASDAQ

If you believe in the massive paradigm shift towards plant based foods and more, be sure to watch and share this great interview with PlantX Founder Sean Dollinger.

St-Georges Eco-Mining $SX.ca $SXOOF Announces $10 Million Financing $NNX.ca $OM.ca $ICM.ca $ATAO

Posted by AGORACOM at 4:18 PM on Wednesday, February 10th, 2021

St-Georges Eco-Mining Corp. (CSE:SX)(OTC:SXOOF) (FSE:85G1) (CNSX:SX.CN)is pleased to announce a non-brokered private placement offering of units at a price of $0.50 and “flow-through” units at a price of $0.60 as well for total gross proceeds of up to $10,000,000.

Each Unit is comprised of one (1) common share (each, a “Share”) in the capital of the Corporation and one (1) Share purchase warrant (each, a “Unit Warrant”), entitling the holder to purchase one (1) Share at an exercise price of $0.65 until first 18 months from the issuance and $1.05 for the 18 months thereafter, together 36 months expiry period (the “Unit Warrant Expiry Date”).

Each FT Unit is comprised of one (1) common share in the capital of the Company on a “flow-through” basis (each, a “FTShare”) and one (1) FT Share purchase warrant (each, a “FT Warrant”). Each FT Warrant entitles the holder thereof to purchase one (1) Share at an exercise price of $0.75 until first 18 months from the issue and $1.25 for the 18 months thereafter, together 36 months expiry period (the “FT Warrant Expiry Date”, together with the Unite Warrant Expiry Date, the “Warrant Expiry Date”).

Read More: https://agoracom.com/ir/St-GeorgesEco-Mining/forums/discussion/topics/755116-st-georges-eco-mining-announces-10-million-financing/messages/2303113#message

SOBRsafe™ $SOBR Pioneers Alcohol Detection for Bus Drivers $LCTC $BLO.ca

Posted by AGORACOM at 12:37 PM on Wednesday, February 10th, 2021

School BUSRide spoke with Kevin Moore, CEO of SOBRsafe™, about touch-based alcohol detection and the difference it can make for school transportation


Kevin Moore, Chief Executive Officer, said that for he and SOBRsafe, child safety represents a chance to make a societal difference with breakthrough technology.


Originally formed by venture capital firm First Capital Ventures, and merged with a detection technology development company, SOBRsafe is at its core a technology and data platform for touch-based alcohol detection – and it is coming to school buses.

“We brought a lot of previously successful people together as the leadership at SOBRsafe,” Moore said. “And one of the key elements for that leadership is to make a difference with this company. We are all at the point in our lives where we want to leave a generational legacy – and child safety is an area where we can make a significant social impact.”

Moore said that American school transportation lacks tools to fully prevent impaired driving, through no fault of the districts and schools themselves. With current capabilities and requirements, alcohol impairment can often go untracked at school bus operations – or tracked with very limited or random screening techniques.

“Every parent treasures their child’s safety,” Moore said, “so we asked ourselves, ‘What if we had a solution that screens 100 percent of bus drivers before they can receive keys and operate a bus?’”

SOBRcheck™

After a lengthy research and development period, SOBRsafe is launching SOBRcheck™ for access control, a patent-pending, proprietary device that provides touch-based identity verification and alcohol detection via a “go/no go” methodology.

When a human ingests alcohol, one of the ways it leaves the body is via transdermal expiration – through the skin. The SOBRcheck™ device does not provide a Blood Alcohol Content (BAC) reading, instead detecting the presence of alcohol in Zero Tolerance situations – like a school bus operation.

The system further functions as a driver/vehicle authenticator by beaming light onto a driver’s skin and creating a set of data points. Those data points then act as that driver’s unique identification. Moore said that this helps alleviate privacy concerns, as the device is not recording fingerprints.

Furthermore, the information that the device collects is immediately transmitted to supervisors via a user-friendly app. This process, Moore said, allows transportation managers, operation managers, and other supervisors to make proactive decisions as opposed to reactive corrections.

“This is the sort of tool which will not only allow school transportation departments to keep children safe, but also provide parents with peace of mind about their child on the bus,” Moore said. “We see preemptive alcohol detection as a critical need for school buses, and feel this device is a phenomenal way to fulfill that need. Systems like this can be essential to ensure that school buses are substance-free environments.”

Kevin Moore, Chief Executive Officer, said that for he and SOBRsafe™, child safety represents a chance to make a societal difference with breakthrough technology.

A unique model

Moore said that SOBRsafe’s intellectual property is currently focused on alcohol detection, but the company is exploring technology centered around detection of cannabis, opioids, and other illicit drugs – as driven by employer need and market demand.

“The key to SOBRsafe is that we are not out developing technologies that require years of testing before commercialization,” Moore said. “We are an integrator of technologies. So, in addition to our internal alcohol detection development, we are looking for other commercially-ready technologies that might work within our system architecture.”

In addition to pursuing other substance detection solutions, Moore said that SOBRsafe is continuing to develop additional value-added features for its devices. The company is launching a new employee health and wellness platform soon, and is implementing GPS location, temperature checks, and more physiology-based technology into its devices for future deployments.

“There is a tremendous amount of emerging technology that can provide a huge benefit for schools and transportation operations,” he said. “We just have to find it, prove its effectiveness, and integrate it into our solutions.”

Deploying to school buses

Moore said that SOBRsafe moved through several prototypes and multiple human trials of the SOBRcheck device, as refining the technology’s various algorithms and detection processes is an exacting, time-consuming task. This was especially so in the wake of the nation’s COVID-19 shutdowns, extending the time required for effective pilot programs.

Once the current round of “production tooling” is complete, the company will launch another pilot program – and then go to market for school districts in the second quarter of 2021.

“We are accelerating the intervention process for school districts,” he said. “Driving under the influence is a serious matter, and intervention can reduce accidents, litigation, deaths, and operating costs.”

More than anything, Moore said, the company’s core objective is safety and saving lives, with child safety at the forefront.

“The feedback we are getting is extremely positive because there is a need in pupil transportation that has not been properly addressed with legacy technology,” Moore said. “When supervisors can proactively make critical decisions by using this data, it is going to improve productivity and save lives.”

TAAT $TAAT.ca $TOBAF Increases Manufacturing Output by 233% to More Than 57,000 Cartons Per Month in Response to Sustained Demand in Ohio

Posted by AGORACOM at 10:39 AM on Wednesday, February 10th, 2021
  • TAAT’s flagship product is now being manufactured at a rate of more than 57,000 ten-pack cartons per month
  • This reflects a 233% increase from a production rate of 12 pallets per month to 40 pallets per month as of this week
  • Improvements to TAAT’s processing facility in Nevada enable it to produce a greater volume of Beyond Tobacco, the product’s base material

LAS VEGAS and VANCOUVER, British Columbia, Feb. 10, 2021 (GLOBE NEWSWIRE) — TAAT ™ LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “TAAT ™ ”) is pleased to announce that its flagship product TAAT ™ is now being manufactured at a rate of more than 57,000 ten-pack cartons per month (over 690,000 cartons per year), which reflects a 233% increase from a production rate of 12 pallets per month to 40 pallets per month as of this week.

This increase was prompted by sustained demand for TAAT™ in Ohio as well as anticipated demand from smokers aged 21+ in other U.S. states who will be able to purchase TAAT™ online directly from the Company when its e-commerce portal launches this quarter.

Recent improvements to the Company’s processing facility in Las Vegas, Nevada have enabled TAAT™ to produce a greater volume of Beyond Tobacco™, the product’s base material which is refined in-house using a 14-step process including a patent-pending refinement technique.

Additionally, the Company has coordinated with its contract manufacturer, who also produces cigarettes for regional and global tobacco brands, to allocate additional production bandwidth to making TAAT™ in order to maintain the current output with the ability to scale further upward as needed.

Read More: https://agoracom.com/ir/TAAT/forums/discussion/topics/755069-taat-tm-increases-manufacturing-output-by-233-to-over-57-000-cartons-per-month-in-response-to-sustained-demand-in-ohio/messages/2303012#message

Agoracom Welcomes Chilean Metals Inc. $CMX.ca $CMETF Leading the Charge of The #Battery Metal Revolution $FCC.ca $CCW.ca $FPX.ca

Posted by AGORACOM at 8:47 AM on Wednesday, February 10th, 2021

Why Chilean Metals Inc?

CMX:TSXV

 Chilean Metals Highlights:

  • Q1: Drill results begin on 3 projects over next 3-4 Q’s 
  • Recent acquisitions predominantly share based transactions 
  • Agreement for up to 80% of the NISK property, Chibougamau Quebec
    • High-grade nickel copper resource at Nisk targets batteries for the EV industry 
  • Golden Ivan Project Acquisition
    • 3 perceived porphyry anomalies identified in Golden Triangle 
    • Ascot Resources is financed to build a mine kilometers from Ivan
  • Copaquire copper-molybdenum deposit 3-per-cent NSR 
    • Chilean Metals sold its Copaquire property to Teck Resources Limited for $C3,033,500, with CMX retaining a 3% NSR (net smelter return) royalty on production.
    • Teck developing Copaquire triggers royalty 
    • Royalty a potential near term cash flow if sold
  • 100-% owner of five Projects in the prolific iron-oxide-copper-gold belt of northern Chile 
    • Commenced drilling on the Tierra De Oro Project 
    • Phase 1 of drilling at its Tierra de Oro has returned 716g/t Silver 0.453% Copper over 2m

Key Projects:

Niska: PGM/Battery Metals, Chibougamau Quebec  

Measured Resource:

  • 1,255,000T at 1.09% Ni; 0.56% Cu; 0.07% Co; 1.11 g/t Pd and 0.20 g/t Pt 

Indicated resource:

  • 783,000T at 1.00% Ni; 0.53% Cu; 0.06% Co; 0.91 g/t Pd and 0.29 g/t Pt 

Inferred resource:

  • 1,053,000T at 0.81% Ni; 0.32% Cu; 0.06% Co; 1.06 g/t Pd and 0.50 g/t Pt c    

About the NISK Property

The NISK property comprises two discontinuous blocks comprising a total of 90 mineral claims fora total of 4,589.11 ha.

  •  NISK-1 block comprises 86 mineral claims for a total of 4,375.55ha, while  
  • the smaller NISK-2 block comprises 4 mineral claims for a total of 312.56 ha. Together these comprise the NISK property comprising a total of 90 mineral claims for a total of 4,589.11 ha,  

The NISK property lies approximately 284 km by road north of the mining town of Chibougamau

  • 45 km east of the Nemiscau airport, in the James Bay territory of Quebec. 
  • NISK Deposit is open at depth and along strike and poised for expansion 

Future Work:
Chilean plans to further advance the previously defined historic resources with confirmation drilling, additional infill, and resource definition drilling commencing in Q2.

  • An updated resource estimate will be prepared upon completion of the additional drilling.
  • Surface exploration is also contemplated for other prospective targets on the property.

Golden Ivan Project 

  • 3 kilometers East of Stewart, BC 
  • Heart of the golden triangle.  
  • Property hosts two known mineral showings:
    • (Gold Ore and Magee)
    • Portion of the past-producing Silverado mine,  
  • Mineral showings are described to be Polymetallic veins that contain quantities of silver, lead, zinc, plus/minus gold and plus/minus copper.
  • Predominantly all share transaction with $1.8m of work commitments

About the Golden Ivan Property 

  • The Golden Ivan property is situated toward the south of British Columbia’s prolific ‘Golden Triangle  
  • The Golden Ivan property is located approximately 15km south west of the Red Mountain Gold/Silver deposit and 30 km south of the historic Premier Gold mine. 
  • Several mineralized veins of the Porter–Idaho Deposit strike onto the Golden Ivan property’s  
  • The property is under explored, however 3 anomalies identified for future exploration 

Future Exploration:   

The initial phase of exploration is anticipated to include:  

  • systematic geological structural and alteration mapping
  • geochemical sampling across the property to determine any local areas of anomalism 
  • ground-based geophysics to confirm local structural trends
    •  initial drill program expected in the summer of 2021.

Previous Work:   

The property hosts two (2) known mineral showings (Gold Ore, and Magee),and a portion of the past producing Silverado Mine, which was reportedly exploited between 1921 and 1939.  

  • Mineral showings are described to be Polymetallic veins that contain quantities of Silver, Lead, Zinc +/- Gold +/- Copper.  
  • Numerous additional mineral occurrences, showings and past procuring mines are located in the immediate areas surrounding the property, further supporting the presence of widespread mineralization in the areas.   

In 2018 Precision Geophysics completed an 88-line kilometre combined magnetic and gamma-ray spectrometry survey on behalf of the vendor Granby Gold Inc. Standard magnetics and radiometric data products were prepared and additional interpolate structural analyses were performed on the collected data.  

  • A number of areas of coincident magnetic and radiometric anomalism have been identified, additionally ‘structurally prepared’ zones are identified from the structural analysis interpolates.  
  • Such characteristics are widely regarded as favourable indicators of widespread hydrothermal alteration aka Porphyries, and will likely aid in vectoring toward any causative source intrusions that may be located on the property.  

Teck Royalty

Chilean Metals sold its Copaquire property to Teck Resources Limited for Cad. $3,033,500, with CMX retaining a 3% NSR (net smelter return) royalty on production.

  • Teck has the right to purchase one third of the NSR for Cad. $3,000,000, thereby presenting the Company with near-term cash flow potential.

The royalty, whether 3% or reduced to 2% through Teck exercising its right,

  • has potential to provide significant future benefit to the Company in terms of non-dilutive exploration funding and/or
  • dividends to our shareholders,
  • may provide a model for the Company’s future accretive growth.

Copaquire is located in Chile’s 1st Region, 125 kms south of its capital city, Iquique, on upland plateau in a very well-endowed mineral neighbourhood and readily accessible via well-maintained all-weather roads.

The project adjoins Teck’s Quebrada Blanca mine, where leachable copper reserves will be depleted by 2016 at current production and reserve levels (Teck website). Anglo-Xstrata-Mitsui’s colossal Collahuasi copper mine also lies nearby.

Copaquire boasts two 43-101-compliant resources:

  • Sulfato South (dominantly copper) 
  • Cerro Moly (dominantly molybdenum)

Tierra de Oro

  • Tierra Del Oro (Land of Gold) project in 3rd Region of Atacama about 75 km south of Copiapó, Chile.
  • Future work involves a targeted Geophysics
  • Coordinate 2nd drill program in Q3

Previous exploration data generated by both the company and other historic operators have been compiled and 8,660 training points were subjected to evaluation by Windfall’s propriety CARDS AI model. CARDS uses data mining techniques to analyze compiled exploration data and to identify areas target zones with high statistical similarity to known “signatures” of areas of copper, gold, and silver mineralization (Figures 3 and 4 below). A total of thirteen (13) prospective target zones were identified by the prediction analysis, of which in Phase 1 the company has elected to drill test two of the zones.

  • The ‘Chanchero’ Zone has previously been identified as being prospective for copper porphyry-style mineralization. The area comprises a 0.75 square kilometers zone of argillic and quartz-sericite-pyrite alteration hosted by augite-hornblende diorite to granodiorite with roof pendants of hornblende monzonite. The area was surveyed by 3-D Induced Polarization (IP) methods in 2008 and generated a chargeability anomaly greater at than 50MV/V at its core which is open at depth. The area was the focus of four (4) core holes that proposed to intersect the chargeability anomaly longitudinally and at depth. A two-meter sample at 120 m depth had a grade of 716 g / t Silver and 0.453% Copper was intersected in hole 3 on the figure below.

Figure 1: Locations of 4 Proposed drill holes at the Chanchero target, relative to the outline/projected shape of the greater at than 50MV/V chargeability anomaly as defined by the 2008 3-D Induced Polarization survey.

The ‘Cobalt’ zone is an AI generated target Gold anomaly that occurs along a pronounced structure and is located along strike from existing shallow artisanal gold workings. A single core hole was orientated to intersect the structure at depth below the projected level of the adjacent historical workings. No material results were generated at this target during the drilling.

Figure 3: Tierra De Oro property CARDS target model-A for Gold anomalism.

Figure 4: Tierra De Oro property CARDS target model-A for Copper anomalism.

https://cdn.investingnews.com/app/uploads/2021/02/chilean_fig4.jpg

PlantX $PLTXF $VEGA.ca Announces Record-Breaking Monthly Gross Revenue of $1,089,502 for January 2021 $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 8:42 AM on Wednesday, February 10th, 2021
  • Achieved record monthly gross revenue of $1,089,502 for the month of January 2021

VANCOUVER, BC , Feb. 10, 2021 – PlantX Life Inc. (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF) (” PlantX ” or the ” Company “) is pleased to announce that it achieved record monthly gross revenue of $1,089,502 for the month of January 2021 . Cost of Goods Sold were $751,356 for the same month.

For the month of December 2020 and during the highly dynamic holiday season, the Company achieved gross revenue of $1,029,883 . This was surpassed by January 2021’s revenue, which exceeded management’s expectations given that e-commerce sales were expected to be slower following the holiday season. This success during one of the slowest e-commerce periods of the year highlights the tremendous impact the Company continues to have in the plant-based marketplace. The Company’s growth continues to be driven by its marketing and branding efforts, as well as the Company’s innovative partnerships. The strong sales figures reflect PlantX’s values-driven approach to successfully meeting consumer demand.

“It is truly encouraging to achieve yet another incredible revenue milestone and to start the new year with such vigor and success,” said PlantX CEO Julia Frank . “There are many other colourful growth opportunities on the horizon, and we’re confident that our financial trajectory will reflect the remarkable and increasing value our Company brings to the plant-based industry.”

The financial results disclosed in this press release are management prepared and have not been audited or reviewed by the Company’s auditors. Unless otherwise indicated, all amounts are expressed in Canadian dollars.

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of likeminded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life.

The Company website is http://investor.PlantX.com/ .

Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may,” “will,” “expect,” “likely,” “should,” “would,” “plan,” “anticipate,” “intend,” “potential,” “proposed,” “estimate,” “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes, without limitation, the business and strategic plans of the Company.

By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate; that assumptions may not be correct; and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to comply with all applicable governmental regulations, including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history; the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.

Additional risk factors can also be found in the Company’s continuous disclosure documents, which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Read More: https://agoracom.com/ir/PlantX/forums/discussion/topics/755080-plantx-announces-record-breaking-monthly-gross-revenue-of-1-089-502-for-january-2021/messages/2303027#message

Peak $PKK.ca $PKKFF Successfully Tests Fund Transfer Process from China to Canada $MOS.ca $MOGO.ca CTZ.ca $TRAD.ca

Posted by AGORACOM-JC at 8:25 AM on Wednesday, February 10th, 2021
Peak Fintech Group (@PEAK_Fintech) | Twitter
  • Announced that it has successfully tested the process whereby the its Chinese operating subsidiaries will periodically send funds back to Canada once the Company becomes profitable and deems it appropriate for its subsidiaries to do so.
  • “Today’s announcement has been several years in the making,” commented Peak CEO Johnson Joseph. “We’ve been following our advisors’ advice from day one and were always confident that the process would work as described.

Montreal, Quebec–(February 10, 2021) – Peak Fintech Group Inc. (CSE: PKK) (OTCQX: PKKFF) (“Peak” or the “Company”), an innovative Fintech service provider to the Chinese commercial lending sector, today announced that it has successfully tested the process whereby the its Chinese operating subsidiaries will periodically send funds back to Canada once the Company becomes profitable and deems it appropriate for its subsidiaries to do so.

Long before establishing its operating subsidiaries in China, Peak worked with business consultants, tax experts, legal and financial advisors specialized in helping foreign entities do business in China. Together they helped Peak create and put in place a corporate structure and file the necessary paperwork so that Peak’s subsidiaries could eventually follow a government-established process to send funds to the Company’s Canadian head office. Part of the exercise required a disclosure process with various government departments at the time of registration and creation of each subsidiary, and the continuous maintenance in good standing of prescribed regulations, all of which led to the first successful transfer of funds from Peak’s Asia Synergy Data Solutions subsidiary to the Company.

“Today’s announcement has been several years in the making,” commented Peak CEO Johnson Joseph. “We’ve been following our advisors’ advice from day one and were always confident that the process would work as described. But until recently we weren’t in a position to test it or had real grounds to do so. However, given the path that the Company is currently on and the possibility of repatriating funds from China at some point in 2021, we felt it was important for us to test the process to ensure that it actually works. We have now validated that we have a clear path and process, endorsed and prescribed by the Chinese government authorities, for our subsidiaries to send funds from China to Canada. We’re also very pleased with the amount we were able to transfer and how quickly the transaction was completed.”

Read more: https://agoracom.com/ir/PeakFintechGroup/forums/discussion/topics/755074-peak-successfully-tests-fund-transfer-process-from-china-to-canada/messages/2303017#message

Xphyto $XPHY.ca $XPYHF to Produce Mescaline for Psychedelic Programs $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 8:21 AM on Wednesday, February 10th, 2021
  • Focused on the synthesis of pharmaceutical grade mescaline
  • Mescaline has shown particular promise for the treatment of addiction and depression.

Xphyto Laboratories Inc., Xphyto Therapeutics Corp.’s wholly owned Alberta subsidiary, has added mescaline production to its psychedelic medicine programs. Further to the Company’s press release dated February 3, 2021, the capacity under contract with Applied Pharmaceutical Innovation will focus on the synthesis of pharmaceutical grade mescaline. Mescaline has been anecdotally recognized as a relatively safe psychedelic drug and has shown particular promise for the treatment of addiction and depression.

“In addition to our European-based psilocybin biotechnology production, the Company has now expanded its portfolio of psychedelic compounds to include mescaline. Our goal is to develop industrial scale production processes for the wholesale market and for incorporation into XPhyto’s thin film drug delivery platforms” commented Hugh Rogers, CEO & Director. “We see a significant market opportunity in the production of pharmaceutical mescaline and the standardization of dosage formulations with precise, predictable and efficient drug delivery for clinical study and therapeutic use”

Mescaline (3,4,5-trimethoxyphenethylamine) is a naturally occurring psychedelic compound found in certain cacti, including peyote, San Pedro, and Peruvian torch, and is most commonly associated with traditional Native American religious rituals and ceremonies. Mescaline is a Schedule I drug in the United States; however, it is legal in certain religious ceremonies registered by the Native American Church and its use is expanding as a supplement to various types of meditation and psychedelic therapy.

In general, psychedelic compounds have emerged as a new class of drugs with the potential to improve the treatment of mental health related medical conditions such as depression, anxiety, addiction, and trauma-related stress disorder. The Company believes that the industrial-scale production of pharmaceutical grade psilocybin and mescaline will provide a strong foundation for its psychedelic medicine programs.

Read More:https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/755075-xphyto-to-produce-mescaline-for-psychedelic-programs/messages/2303018#message

FansUnite $FANS.ca $FUNFF Signs Engagement Letter with Gaming Law Firm to Pursue U.S. Licensing Strategy $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 8:12 AM on Wednesday, February 10th, 2021

  • Announced that the Company engaged the services of Ifrah Law PLLC, a prominent U.S. gaming law firm to collaborate with OneComply Inc. in assisting FansUnite with their U.S. licensing strategy.
  • Ifrah Law will guide FansUnite in navigating multiple state licenses in 2021, starting with New Jersey

Vancouver, British Columbia–(February 10, 2021) – FansUnite Entertainment Inc. (CSE: FANS) (OTCQB: FUNFF) (“FansUnite” or the “Company”) is pleased to announce that the Company engaged the services of Ifrah Law PLLC (“Ifrah Law”), a prominent U.S. gaming law firm to collaborate with OneComply Inc. (“OneComply”) in assisting FansUnite with their U.S. licensing strategy.

In response to the interest that FansUnite has received from U.S. gambling and casino operators for their sports betting and iGaming solutions, a founding member of Ifrah Law, Jeff Ifrah, will provide counsel to FansUnite on their rapid expansion strategy across the different U.S. jurisdictions beginning with New Jersey.

Jeff is an accomplished lawyer who is nationally ranked by Chambers USA in Gaming & Licensing Law given his reputation for legal excellence as well as his involvement with major prosecutions and lawsuits in the North American iGaming industry. Jeff’s expertise and extensive experience in the U.S. gaming landscape will be integral to FansUnite’s growth in the U.S. online gambling market as the Company seeks to acquire multiple state licenses in 2021, starting with the gaming license of New Jersey. In addition, Jeff has worked with OneComply on numerous occasions and therefore, his contribution will bolster OneComply’s efforts in streamlining the legal process for FansUnite’s entry into the U.S.

“Jeff and his team are a great addition to the global legal team that we have assembled to oversee the delivery of FansUnite’s offerings,” said Scott Burton, CEO of FansUnite. “With a long-standing career as a prominent attorney in gaming law, Jeff will accelerate our expansion into the highly complex U.S. betting and iGaming market.”

Read More: https://agoracom.com/ir/FansUniteEntertainment/forums/discussion/topics/755073-fansunite-signs-engagement-letter-with-gaming-law-firm-to-pursue-u-s-licensing-strategy/messages/2303016#message